NCT04125342View on ClinicalTrials.gov

Postextubation High-flow Therapy vs Noninvasive Ventilation in Obese or at High-risk Patients

NACompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

December 1, 2021

Conditions
Extubation Failure
Interventions
DEVICE

Preventive Conditioned NIV Therapy after planned extubation

Conditioned NIV during 48 hours following extubation.

DEVICE

Preventive HFOT after planned extubation

HFOT set according to patients tolerance during 48 hours following extubation

Trial Locations (2)

28006

La princesa University Hospital, Madrid

45007

Hospital Virgen de la Salud, Toledo

All Listed Sponsors
lead

Hospital Virgen de la Salud

OTHER

NCT04125342 - Postextubation High-flow Therapy vs Noninvasive Ventilation in Obese or at High-risk Patients | Biotech Hunter | Biotech Hunter